Inactive Instrument

China Biologic Products Holdings, Inc. Stock price

Equities

CBPO

KYG215151047

Biotechnology & Medical Research

Dynamic Chart
China Biologic Products Holdings, Inc.(NasdaqGS:CBPO) dropped from S&P Global BMI Index CI
China Biologic Products Holdings, Inc.(NasdaqGM:CBPO) dropped from FTSE All-World Index CI
China Biologic Products Holdings, Inc.(NasdaqGS:CBPO) dropped from NASDAQ Biotechnology Index CI
China Biologic Products Holdings, Inc.(NasdaqGM:) dropped from NASDAQ Composite Index CI
Centurium Capital Management Ltd., CITIC Capital Partners Management Ltd., Parfield International Ltd., V-Sciences Investments Pte Ltd, Hillhouse Capital Management, Ltd. and Joseph Chow, Chairman and Chief Executive Officer of China Biologic Products Holdings, Inc. completed the acquisition of remaining 31.16% stake in China Biologic Products Holdings, Inc.. CI
China Biologic Products Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
China Biologic Products : Q4 Profit, Revenue Rise from Year Ago MT
China Biologic Products Holdings, Inc. Announces Resignation of Yue’e Zhang from the Board of Directors CI
Joseph Chow, the Chairman of the Board of Directors and Chief Executive Officer of CBPO completed the acquisition of 9.72% stake in China Biologic Products Holdings, Inc. from PW Medtech Group Limited. CI
Joseph Chow, the Chairman of the Board of Directors and Chief Executive Officer of CBPO completed the acquisition of 2% stake in China Biologic Products Holdings, Inc. from PW Medtech Group Limited. CI
CITIC Capital Holdings Limited completed the acquisition of 2.4% stake in China Biologic Products Holdings, Inc. from PW Medtech Group Limited. CI
Transcript : China Biologic Products Holdings, Inc., Q3 2020 Earnings Call, Nov 25, 2020
China Biologic Products Holdings, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020 CI
China Biologic Products : Q3 Adj. EPS Slips From Year-Ago Levels But Sales Climb Nearly 2% MT
China Biologic Products : to Merge With CBPO Group in Going-Private Deal; Shares Gain Pre-Bell MT
More news
Managers TitleAgeSince
Chief Executive Officer 60 14-11-02
Corporate Officer/Principal - -
Members of the board TitleAgeSince
Chief Executive Officer 60 14-11-02
Director/Board Member 67 08-07-23
More insiders
China Biologic Products Holdings Inc is a China-based company. The Company operates as a biopharmaceutical company. The Company research, develop, and produces human plasma-based pharmaceutical and coagulation factor products in the form of tablets, injections, capsules, and syrups. Company also distributes pharmaceutical products. It serves clients in China.
More about the company
  1. Stock
  2. Equities
  3. Stock China Biologic Products Holdings, Inc. - Nasdaq